Betmiga 25mg Tablet
Prescription Required
Product introduction
Betmiga 25mg Tablet is used to treat symptoms of overactive bladder that includes increased or frequent urination, urgent need to urinate and inability to control urination. It helps to relax the muscle surrounding the bladder and increase it's ability to store urine.
Betmiga 25mg Tablet is a beta 3-receptor agonist.
Betmiga 25mg Tablet is a beta 3-receptor agonist.
Uses of Betmiga Tablet
Benefits of Betmiga Tablet
In Treatment of Overactive bladder (OAB) symptoms
Betmiga 25mg Tablet helps to treat uncontrollable contractions (spasms) of the bladder muscles that cause frequent urination, urgent need to urinate, and inability to control the passing of urine. It also relieves painful, or frequent urination and reduces the urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.
Side effects of Betmiga Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Betmiga
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Betmiga Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Betmiga 25mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Betmiga 25mg Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Betmiga 25mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Betmiga 25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
SAFE
Betmiga 25mg Tablet does not usually affect your ability to drive.
Kidney
CAUTION
Betmiga 25mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Betmiga 25mg Tablet may be needed. Please consult your doctor.
Liver
CAUTION
Betmiga 25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Betmiga 25mg Tablet may be needed. Please consult your doctor.
Use of Betmiga 25mg Tablet is not recommended in patients with severe liver disease.
Use of Betmiga 25mg Tablet is not recommended in patients with severe liver disease.
What if you forget to take Betmiga Tablet?
If you miss a dose of Betmiga 25mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Betmiga 25mg Tablet
₹68.52/Tablet
Mirakem 25mg Tablet
Alkem Laboratories Ltd
₹24/tablet
62% cheaper
Begberon 25mg Tablet
Leeford Healthcare Ltd
₹25/tablet
60% cheaper
Oabf 25mg Tablet
Alembic Pharmaceuticals Ltd
₹21/tablet
67% cheaper
Mirafast 25mg Tablet
Future Pharma Pvt Ltd
₹20.2/tablet
68% cheaper
Quick tips
- Betmiga 25mg Tablet helps you to have better control over your urination. It relaxes your bladder which increases its capacity to hold urine thereby reducing the need to pass urine.
- It causes less drowsiness and constipation than other medicines for overactive bladder.
- It may raise your blood pressure. Monitor your blood pressure regularly.
- Do not stop taking this medicine if you do not notice an improvement in your symptoms as it may take some time for your bladder to adapt and your symptoms to improve.
Fact Box
Chemical Class
Anilide Derivative
Habit Forming
No
Therapeutic Class
UROLOGY
Action Class
Selective beta 3-adrenoceptor agonist (Bladder)
Patient concerns
FAQs
Q. How long does it take for Betmiga 25mg Tablet to show its effects?
You may see the full benefits of Betmiga 25mg Tablet after 8 weeks of starting the treatment or longer. Depending on how well the medicine suits and affects the patient, the dose can be increased after 4-8 weeks.
Q. Can I stop taking Betmiga 25mg Tablet if I start feeling better?
No, do not stop taking Betmiga 25mg Tablet even if you start feeling better. This medicine does not cure overactive bladder but relieves the symptoms of urgency, frequency and incontinence (unable to control when you empty your bladder). Stopping treatment may result in a recurrence of the symptoms of overactive bladder.
Q. Does Betmiga 25mg Tablet cause loss of sleep?
No, Betmiga 25mg Tablet does not affect your sleep. However, if you are having any problems related to your sleep, talk to your doctor.
Q. What is the effect of Betmiga 25mg Tablet in children?
It is best to avoid the use of Betmiga 25mg Tablet in children because its effectiveness and side effects in children (age < 18 years) have not been studied yet.
Q. Can I take Betmiga 25mg Tablet off and on?
No, you need to take it daily as directed by your doctor since it controls your condition and does not cure it. Your bladder takes time to adapt to the medicine, so if you take it off and on, you will not get the desired benefits and your symptoms will recur.
Q. Does Betmiga 25mg Tablet affect the kidneys?
Infection of kidneys, ureters, urinary bladder or urethra is a common side effect of Betmiga 25mg Tablet but does not affect everyone. Very few patients have reported of developing renal stones and bladder pain with the use of Betmiga 25mg Tablet. Also, patients with compromised kidney function should be careful while using Betmiga 25mg Tablet and report any unwanted symptoms related to kidneys to the consulting doctor.
Q. Do I need to be careful while taking Betmiga 25mg Tablet if I am taking medicines to control my blood pressure?
Yes, you need to be careful while taking Betmiga 25mg Tablet if you have high blood pressure. Keep a regular check on your blood pressure since Betmiga 25mg Tablet can cause an increase in blood pressure in some people. It should not be used in patients with severe uncontrolled hypertension.
Q. What if I accidentally take more than the required dose of Betmiga 25mg Tablet?
You should seek urgent medical attention even if do not feel any discomfort. Overdose of Betmiga 25mg Tablet may increase your pulse rate and blood pressure. As a result of this, you may experience severe headache, palpitations, chest pain and fatigue.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 924-25.
- Medscape. Mirabegron. [Accessed 04 Apr. 2019] (online) Available from:
- Mirabegron. Chertsey, Surrey: Astellas Pharma Ltd.; 2012 [revised 18 Sep. 2017]. [Accessed 25 Jan. 2019] (online) Available from:
- Mirabegron. Norman, Oklahoma: Astellas Pharma Technologies, Inc; 2012. [Accessed 04 Apr. 2019] (online) Available from:
- National Health Services. Mirabegron. [Last Reviewed: 28 Jul. 2020]. [Accessed 11 Jul. 2023]. (online) Available from:
- CiplaMed. Mirabegron [Prescribing Information]. [Last Reviewed: Jan. 2019]. [Accessed 11 Jul. 2023]. (online) Available from:
Marketer details
Name: Astellas Pharma Inc
Address: Astellas Pharma India Pvt Ltd, 301, 3rd Floor, C and B Square, 127 Andheri Kurla Road, Chakala, Andheri East, Mumbai 400 069.
Country of origin: India
Lab tests offered by us
Related/Popular tests
137 people viewed this recentlyMRP
₹685.2
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me